Type 2 diabetes mellitus has become a major lifestyle-related health challenge in India, affecting millions of people across different age groups. Poor glycaemic control not only leads to high blood sugar levels but also increases the risk of serious complications such as heart disease, kidney damage, nerve problems, and reduced quality of life. Modern diabetes management focuses not only on controlling blood glucose but also on protecting vital organs like the heart and kidneys.
PAFAGOLD 10, containing Dapagliflozin 10 mg, is an advanced oral antidiabetic medication belonging to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). It works through a unique insulin-independent mechanism by promoting the excretion of excess glucose through urine. This innovative approach makes dapagliflozin an effective and well-tolerated option for long-term diabetes management.
In addition to blood sugar control, PAFAGOLD 10 has shown significant benefits in reducing cardiovascular risk and slowing the progression of chronic kidney disease, making it a valuable therapy for patients with multiple metabolic concerns.
Uses of PAFAGOLD 10
PAFAGOLD 10 is prescribed for the management of diabetes and related conditions, especially in patients who require comprehensive metabolic and organ protection.
Key uses include:
Treatment of Type 2 diabetes mellitus in adults
Blood glucose control as monotherapy or in combination with other antidiabetic medicines
Management of diabetes in patients with overweight or obesity
Reduction of risk of hospitalization due to heart failure
Management of heart failure with reduced ejection fraction (HFrEF)
Slowing progression of chronic kidney disease in diabetic patients
Improvement of overall metabolic control alongside diet and exercise
PAFAGOLD 10 is not indicated for type 1 diabetes or diabetic ketoacidosis unless specifically advised by a specialist.
Benefits of PAFAGOLD 10
PAFAGOLD 10 offers multiple clinical and patient-centric benefits, making it a preferred choice in modern diabetes care:
Effective reduction in blood glucose levels without excessive insulin stimulation
Low risk of hypoglycaemia when used alone
Promotes weight loss by eliminating excess glucose calories
Helps reduce blood pressure mildly due to osmotic diuresis
Proven cardioprotective benefits, especially in heart failure patients
Slows progression of diabetic kidney disease
Improves overall metabolic health and energy levels
Suitable for long-term use with good tolerability
These benefits make PAFAGOLD 10 an ideal choice for patients requiring holistic diabetes management beyond sugar control alone.
Dosage
The dosage of PAFAGOLD 10 should always be individualized based on the patient’s clinical condition, renal function, and treatment goals. It must be taken only under medical supervision.
General dosage recommendations include:
Standard dose: Dapagliflozin 10 mg once daily
Can be taken with or without food
Tablet should be swallowed whole with water
Best taken at the same time each day for consistency
No dose adjustment is usually required in mild renal impairment, but monitoring is essential
Patients should continue their prescribed diet, exercise, and lifestyle modifications alongside medication. Regular blood sugar and kidney function monitoring is advised.
Side Effects of PAFAGOLD 10
PAFAGOLD 10 is generally well tolerated; however, some patients may experience side effects, especially during the initial phase of treatment.
Common side effects include:
Increased frequency of urination
Genital fungal infections
Urinary tract infections
Thirst or mild dehydration
Less common side effects:
Dizziness or weakness
Mild drop in blood pressure
Back pain
Rare but serious side effects:
Diabetic ketoacidosis (even with moderately elevated glucose)
Severe urinary infections
Acute kidney injury in high-risk patients
Prompt medical attention is required if symptoms such as persistent nausea, vomiting, abdominal pain, or breathing difficulty occur.
Precautions and Warning
Certain precautions must be followed before and during treatment with PAFAGOLD 10 to ensure safe use:
Not recommended in Type 1 diabetes mellitus
Avoid use in patients with severe renal impairment or dialysis
Use cautiously in elderly patients due to dehydration risk
Maintain adequate hydration to prevent low blood pressure
Inform the doctor about ongoing infections or recent surgeries
Temporary discontinuation may be required during prolonged fasting or severe illness
Not recommended during pregnancy and breastfeeding unless clearly advised
Patients with recurrent genital infections should be closely monitored
Regular follow-up and laboratory monitoring help minimize risks and optimize therapeutic outcomes.
Conclusion
PAFAGOLD 10 Dapagliflozin 10 mg represents a modern, evidence-based approach to managing type 2 diabetes while addressing its most serious complications—heart and kidney disease. Its unique insulin-independent mechanism provides effective glycaemic control with added benefits such as weight reduction, cardiovascular protection, and renal support.
With a favourable safety profile and proven long-term benefits, PAFAGOLD 10 is an excellent therapeutic option for patients requiring comprehensive metabolic care. When used responsibly under medical guidance and combined with healthy lifestyle practices, it helps patients achieve better blood sugar control, improved organ protection, and enhanced quality of life.
